SNOA
Price:
$3.8633
Market Cap:
$3.96M
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a HOCl-based topical prescription product indicated to promote efficient healing through the management of new and old scars; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2007-01-25
Stock Exchange
NASDAQ
Ticker
SNOA
According to Sonoma Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.79M. This represents a change of -96.97% compared to the average of 59.22M of the last 4 quarters.
The mean historical Enterprise Value of Sonoma Pharmaceuticals, Inc. over the last ten years is 225.78M. The current 1.79M Enterprise Value has changed -20.55% with respect to the historical average. Over the past ten years (40 quarters), SNOA's Enterprise Value was at its highest in in the March 2017 quarter at 585.43M. The Enterprise Value was at its lowest in in the December 2023 quarter at 37.36M.
Average
225.78M
Median
181.46M
Minimum
25.30M
Maximum
588.67M
Discovering the peaks and valleys of Sonoma Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 107.01%
Maximum Annual Enterprise Value = 588.67M
Minimum Annual Increase = -69.59%
Minimum Annual Enterprise Value = 25.30M
Year | Enterprise Value | Change |
---|---|---|
2024 | 25.30M | -60.05% |
2023 | 63.31M | -69.38% |
2022 | 206.74M | -29.93% |
2021 | 295.06M | 107.01% |
2020 | 142.53M | -4.85% |
2019 | 149.80M | -53.72% |
2018 | 323.67M | -45.02% |
2017 | 588.67M | 92.05% |
2016 | 306.51M | 96.25% |
2015 | 156.19M | -69.59% |
The current Enterprise Value of Sonoma Pharmaceuticals, Inc. (SNOA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
98.45M
5-year avg
146.59M
10-year avg
225.78M
Sonoma Pharmaceuticals, Inc.’s Enterprise Value is less than China Pharma Holdings, Inc. (6.75M), less than Universe Pharmaceuticals INC (11.54M), less than Acorda Therapeutics, Inc. (187.38M), less than Akanda Corp. (6.15M), less than Petros Pharmaceuticals, Inc. (3.82M), greater than Sunshine Biopharma, Inc. (-7489992.00), greater than Guardion Health Sciences, Inc. (-1993682.00), less than Alpha Teknova, Inc. (245.85M), less than Cannara Biotech Inc. (114.39M), greater than MC Endeavors, Inc. (660.14K), less than Unrivaled Brands, Inc. (42.89M), greater than GelStat Corporation (744.05K), less than Shionogi & Co., Ltd. (1.51T), less than Alimera Sciences, Inc. (362.58M), greater than China SXT Pharmaceuticals, Inc. (-7302475.00), less than Shuttle Pharmaceuticals Holdings, Inc. (4.22M), less than Lifecore Biomedical, Inc. (279.48M), less than Mallinckrodt plc (2.62B), less than Journey Medical Corporation (112.07M),
Company | Enterprise Value | Market cap |
---|---|---|
6.75M | $3.43M | |
11.54M | $11.35M | |
187.38M | $821.03K | |
6.15M | $2.24M | |
3.82M | $3.64M | |
-7489992.00 | $3.44M | |
-1993682.00 | $12.83M | |
245.85M | $233.47M | |
114.39M | $52.21M | |
660.14K | $485.43K | |
42.89M | $58.13K | |
744.05K | $185.39K | |
1.51T | $12.61B | |
362.58M | $301.29M | |
-7302475.00 | $2.12M | |
4.22M | $3.76M | |
279.48M | $157.58M | |
2.62B | $4.52M | |
112.07M | $113.17M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sonoma Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sonoma Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Sonoma Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Sonoma Pharmaceuticals, Inc. (SNOA)?
What is the 3-year average Enterprise Value for Sonoma Pharmaceuticals, Inc. (SNOA)?
What is the 5-year average Enterprise Value for Sonoma Pharmaceuticals, Inc. (SNOA)?
How does the current Enterprise Value for Sonoma Pharmaceuticals, Inc. (SNOA) compare to its historical average?